Actively Recruiting
Continuous Connected Patient Care (CCPC) Pilot Testing a Novel Device for Continuous Vital Signs Monitoring in Non-Cardiac Surgery Patients
Led by Medtronic - MITG · Updated on 2026-03-12
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Medtronic - MITG
Lead Sponsor
E
Excelar
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the feasibility and accessibility of the Continuous Connected Patient Care (CCPC) Platform, which includes Oxymotion, Bridge Health Solutions medication adherence software, and the CloudDX home kit, in patients undergoing non-cardiac surgery. This pilot study focuses on using the platform in two different settings: in hospital and at home, aiming to monitor continuous vital signs and collect feedback from patients and clinicians. Participants in this observational study will use the CCPC Platform during their inpatient hospital stay and potentially at home. The study monitors patients from enrollment through a follow-up period lasting 10 days. The platform is designed to support medication adherence and continuous vital monitoring using connected devices and software. During the study, researchers will gather feedback from both patients and healthcare providers about the usability and technical performance of the CCPC Platform. Assessments include patient questionnaires and clinician input regarding the device and software functionality. The primary outcomes focus on confirming whether the technical goals of the platform are met and evaluating user feedback throughout the 10-day follow-up period.
CONDITIONS
Brief Title
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 19 years or older
- Patients who have undergone a non-cardiac surgery at SPH requiring an inpatient hospital stay
- Perioperative patients in the Surgical High Acuity Unit (SHAU) or followed by Anesthesia Perioperative Outreach team on the ward
- Living within British Columbia, Canada, in an area covered by Bell cellular network
You will not qualify if you...
- Patient refusal to participate
- Lack of capacity to consent, including recent sedation or general anesthetic within 24 hours
- Unable to use or have caregiver assistance to use the monitoring device at home
- Unable to complete study questionnaires by electronic means, paper, or phone without help
- No access to a cell phone or landline at home for follow-ups
- Preoperatively known discharge to nursing home or rehabilitation facility
- Known allergies to any materials of the study devices
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 10 days
Participants are monitored using the CCPC platform to collect continuous vital signs data and feedback from patients and clinicians.
Continuous monitoring during inpatient hospital stay and follow-up period
Trial Site Locations
Total: 1 location
1
Saint Pauls Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
Actively Recruiting
Research Team
E
Elise Huisman
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here